Browsing by Author Paré, Laia
Showing results 1 to 20 of 21
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 5-Mar-2014 | Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer | Sanz Pamplona, Rebeca; Berenguer, Antoni; Cordero Romera, David; Garcia i Molleví, David; Crous Bou, Marta; Solé Acha, Xavier; Paré, Laia; Guinó, Elisabet; Salazar Soler, Ramón; Santos, Cristina; Oca Burguete, Javier de; Sanjuan, Xavier; Rodríguez Moranta, Francisco; Moreno Aguado, Víctor |
| 6-Mar-2024 | Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy | Pascual, Tomás; Fernández Martínez, Aranzazu; Agrawal, Yash; Pfefferle, Adam D.; Chic Ruché, Núria; Brasó Maristany, Fara; Gonzàlez-farré, Blanca; Paré, Laia; Villacampa, Guillermo; Saura, Cristina; Hernando, Cristina; Muñoz, Montserrat; Galván, Patricia; Gonzàlez Farré, Xavier; Oliveira, Mafalda; Gil Gil, Miguel; Ciruelos, Eva; Villagrasa, Patricia; Gavilá, Joaquín; Prat Aparicio, Aleix; Perou, Charles M. |
| 1-Mar-2023 | Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer | Prat Aparicio, Aleix; Brasó Maristany, Fara; Martínez Sáez, Olga; Sanfeliu, Esther; Xia, Youli; Bellet, Meritxell; Galván, Patricia; Martínez Pérez, Debora; Pascual, Tomás; Marín Aguilera, Mercedes; Rodríguez, Ana Belén; Chic Ruché, Núria; Adamo, Barbara; Paré, Laia; Vidal, Maria; Margelí Vila, Mireia; Ballana, Ester; Gómez Rey, Marina; Oliveira, Mafalda; Felip, Eudald; Matito, Judit; Sánchez Bayona, Rodrigo; Suñol, Anna; Saura, Cristina; Ciruelos, Eva; Tolosa, Pablo; Muñoz, Montserrat; González Farré, Blanca; Villagrasa, Patricia; Parker, Joel S.; Perou, Charles M.; Vivancos, Ana |
| 4-Jan-2021 | Clinical, pathological and PAM50 gene expression features of HER2-low breast cancer | Prat Aparicio, Aleix; Schettini, Francesco; Chic Ruché, Núria; Brasó Maristany, Fara; Paré, Laia; Pascual, Tomás; Conte, Benedetta; Martínez Sáez, Olga; Adamo, Barbara; Vidal Losada, Maria Jesús; Fernández Martínez, Aranzazu; González Farré, Blanca; Sanfeliu, Esther; Cejalvo Andújar, Juan Miguel; Perrone, Giuseppe; Sabarese, Giovanna; Zalfa, Francesca; Villagrasa, Patricia; Gavilá, Joaquín; Barrios, Carlos H.; Lluch, Ana; Martín, Miguel; Placido, Sabino De; Barnadas, Esther; Locci, Mariavittoria; Peg, Vicente; Fasan, Roberta |
| 1-Oct-2022 | COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients | Díez Villanueva, Anna; Sanz Pamplona, Rebeca; Solé, Xevi; Cordero, David; Crous Bou, Marta; Guinó, Elisabet; López Dóriga Guerra, Adriana; Berenguer, Antoni; Aussó, Susanna; Paré, Laia; Obón Santacana, Mireia; Moratalla Navarro, Ferran; Salazar Soler, Ramón; Sanjuan, Xavier; Santos, Cristina; Biondo, Sebastián; Diez Obrero, Virginia; Garcia Serrano, Ainhoa; Alonso Aguado, Maria Henar; Carreras Torres, Robert; Closa, Adria; Moreno Aguado, Víctor |
| 1-Feb-2014 | Discovery and functional assessment of gene variants in the vascular endothelial growth factor pathway | Paré, Laia; Glubb, Dylan; Evans, Patrick; Berenguer, Antoni; Etheridge, Aamy S.; Skol, Andrew D.; Di Rienzo, Anna; Duan, Shiwei; Gamazon, Eric R.; Innocenti, Federico |
| 24-Jul-2015 | Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer. | Cebola, Inés; Custodio, Joaquin; Muñoz, Mar; Díez Villanueva, Anna; Paré, Laia; Prieto, Patricia; Aussó, Susanna; Coll Mulet, Llorenç; Boscá, Lisardo; Moreno Aguado, Víctor; Peinado Morales, Miguel Á. (Miguel Ángel) |
| 14-Jul-2020 | ERBB2mRNA expression and response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-positive breast cancer | Griguolo, Gaia; Brasó Maristany, Fara; González Farré, Blanca; Pascual, Tomás; Chic Ruché, Núria; Saurí, Tamara; Kates, Ronald; Gluz, Oleg; Martínez, Débora; Paré, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz Mateu, Montserrat; Galván, Patricia; Barberá, Laura; Cuatrecasas Freixas, Miriam; Christgen, Mathias; Kreipe, Hans; Monge Escartín, Inés; Villagrasa, Patricia; Soy Muner, Dolors; Giarratano, Tommaso; Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina; Prat Aparicio, Aleix |
| 22-Nov-2021 | Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease | Isola, Ignacio; Brasó-Maristany, Fara; Moreno, David F.; Mena Jaramillo, Mari Pau; Oliver Caldés, Aina; Paré, Laia; Rodríguez-Lobato, Luis Gerardo; Martín-Antonio, Beatriz; Cibeira, María Teresa; Bladé, J. (Joan); Rosiñol Dachs, Laura; Prat Aparicio, Aleix; Lozano Garcia, Ester; Fernández de Larrea Rodríguez, Carlos José |
| 7-Apr-2021 | Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer | Schettini, Francesco; Barbao, P; Brasó Maristany, Fara; Galván, Patricia; Martínez, Debora; Paré, Laia; Placido, Sabino De; Prat Aparicio, Aleix; Guedán Carrió, Sònia |
| 19-Mar-2021 | Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer | Griguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic Ruché, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo |
| 24-Sep-2014 | Large differences in global transcriptional regulatory programs of normal and tumor colon cells | Cordero Romera, David; Solé Acha, Xavier; Crous Bou, Marta; Sanz Pamplona, Rebeca; Paré, Laia; Guinó, Elisabet; Olivares, David; Berenguer, Antoni; Santos, Cristina; Salazar Soler, Ramón; Biondo, Sebastián; Moreno Aguado, Víctor |
| 28-Mar-2017 | Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer | Fernández Martínez, Aranzazu; Pascual, Tomás; Perrone, Giuseppe; Morales, Serafín; Haba, Juan de la; González Rivera, Milagros; Galván, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucía; Prats de Puig, Miquel; Rojo, Federico; Manso, Luis; Paré, Laia; Alonso, Immaculada; Albanell Mestres, Joan; Vivancos, Ana; González, Antonio; Matito, Judit; González, Sonia; Fernández Ruiz, Pedro Luis; Adamo, Barbara; Muñoz Mateu, Montserrat; Viladot, Margarita; Font, Carme; Aya, Francisco; Vidal Losada, Maria Jesús; Caballero, Rosalía; Carrasco, Eva; Altomare, Vittorio; Tonini, Giuseppe; Prat Aparicio, Aleix; Martín, Miguel |
| 18-Sep-2019 | Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial | Adamo, Barbara; Bellet Ezquerra, Meritxell; Paré, Laia; Pascual, Tomás; Vidal Losada, Maria Jesús; Pérez Fidalgo, José A.; Blanch, Salvador; Martínez, Noelia; Murillo, Laura; Gómez Pardo, Patricia; López González, Ana; Amillano, Kepa; Canes, Jordi; Galván, Patricia; González Farré, Blanca; Gonzalez, Xavier; Villagrasa, Patricia; Ciruelos, Eva; Prat Aparicio, Aleix |
| 25-Sep-2019 | PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution | Pernas, Sònia; Petit, Anna; Climent, Fina; Paré, Laia; Perez Martin, J.; Ventura, Luz; Bergamino Sirvén, Milana; Galván, Patricia; Falo, Catalina; Morilla, Idoia; Fernandez Ortega, Adela; Stradella, Stradella; Rey, Montse; García Tejedor, María Amparo; Gil Gil, Miguel; Prat Aparicio, Aleix |
| 20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic Ruché, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
| May-2017 | Resistance to taxanes in triple negative breast cancer associates with the dynamics of a CD49f+ tumor initiating population | Gómez Miragaya, Jorge; Palafox Sánchez, Marta; Paré, Laia; Yoldi, Guillermo; Ferrer, Irene; Vila, Sergi; Galván, Patricia; Pellegrini, Pasquale; Pérez-Montoyo, Hector; Igea, Ana; Muñoz Moruno, Purificación; Esteller, Manel; Nebreda, Àngel R.; Urruticoechea Ribate, Ander; Morilla, Idoia; Pernas, Sònia; Climent, Fina; Soler, María Teresa; Petit, Anna; Serra Elizalde, Violeta; Prat Aparicio, Aleix; González Suárez, Eva |
| 18-Dec-2015 | Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy. | Prat Aparicio, Aleix; Fan, Cheng; Fernández Martínez, Aranzazu; Hoadley, Katherine A.; Martinello, Rossella; Vidal Losada, Maria Jesús; Viladot, Margarita; Pineda, Estela; Arance, Ana; Muñoz Mateu, Montserrat; Paré, Laia; Cheang, Maggie C. U.; Adamo, Barbara; Perou, Charles M. |
| 9-Jan-2019 | Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial | Gavilá, Joaquín; Oliveira, Mafalda; Pascual, Tomás; Pérez-García, José; Gonzàlez, Xavier; Canes, Jordi; Paré, Laia; Calvo Serrano, Isabel; Ciruelos, Eva; Muñoz Mateu, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andrés, Raquel; Perelló, Antonia; Martínez, Jerónimo; Morales, Serafín; Marín Aguilera, Mercedes; Martínez, Debora; Quero, Juan C.; Llombart-Cussac, Antonio; Prat Aparicio, Aleix |
| 23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |